생체 흡수성 의료 재료 시장 보고서(2025년)

Bioresorbable medical materials are substances specifically engineered to be absorbed or broken down by the body over time. These materials find applications in various medical scenarios, including surgical implants and tissue engineering scaffolds. They offer several advantages compared to permanent implants, as they eliminate the need for surgical removal once they have fulfilled their intended function.

The primary types of bioresorbable medical materials include polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL), and polylactic-co-glycolic acid (PLGA). Polylactic acid (PLA) is a biodegradable and bioresorbable polymer derived from renewable sources such as corn starch or sugarcane. PLA is commonly utilized in the production of bioresorbable medical materials, such as sutures, screws, and bone fixation devices. These materials serve diverse applications, including drug delivery and orthopedics, and are utilized by various end-users such as hospitals, clinics, ambulatory surgical centers, and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The bioresorbable medical material research report is one of a series of new reports from The Business Research Company that provides bioresorbable medical material market statistics, including the bioresorbable medical material industry's global market size, regional shares, competitors with a bioresorbable medical material market share, detailed bioresorbable medical material market segments, market trends and opportunities, and any further data you may need to thrive in the bioresorbable medical material industry. This bioresorbable medical material market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bioresorbable medical material market size has grown strongly in recent years. It will grow from $1.56 billion in 2024 to $1.71 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to traditional non-resorbable materials limitations, advancements in polymer science, surge in cardiovascular interventions, growing aging population, expansion of minimally invasive surgeries.

The bioresorbable medical material market size is expected to see strong growth in the next few years. It will grow to $2.51 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing demand for bioresorbable scaffolds, adoption of bioresorbable materials in various medical applications, rise in cardiovascular and orthopedic procedures, growing focus on patient comfort and recovery, expanding applications in tissue engineering. Major trends in the forecast period include customization of bioresorbable materials for specific medical applications, integration of bioresorbable materials in drug delivery systems, growth of 3d printing in bioresorbable medical device manufacturing, development of combination products with bioresorbable elements, emphasis on sustainable and environmentally friendly medical materials,.

The forecast of 10.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. surgical innovation by increasing the cost of absorbable stents and tissue scaffolds sourced from Finland and Italy, thereby delaying adoption of next-generation implants and elevating surgical procedure costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising number of surgeries is expected to drive the growth of the bioresorbable medical material market in the future. Surgical procedures involve medical treatments that require making an incision and utilizing tools to address or repair diseases within a living body. Bioresorbable polymers are utilized in molded medical devices, especially in the fields of neurology, orthopedics, and cosmetic surgery. These materials can be employed to manufacture sutures, anchors, and screws. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization, reported that aesthetic procedures approached nearly 35 million in 2023, with the total number of surgical and non-surgical procedures increasing by 3.4% to 34.9 million. Consequently, the growing number of surgeries is fueling the growth of the bioresorbable medical material market.

The burgeoning aging population is poised to drive the growth of the bioresorbable medical material market significantly. An aging population signifies a demographic shift marked by a higher percentage of individuals aged 65 and above within a society. The increased demand for medical interventions among the elderly, coupled with a preference for advanced bioresorbable solutions that alleviate the necessity for subsequent surgeries to remove implants, fuels the expansion of the bioresorbable medical materials market. For instance, in 2022, according to visual capitalist, a Canadian company specializing in visual content on contemporary trends, the global population aged 65+ years totaled 771 million, accounting for nearly 10% of the world's populace. Therefore, the growing aging demographic is a key driver behind the growth of the bioresorbable medical material market.

The emergence of innovative biomaterials is a significant trend gaining traction in the bioresorbable medical material market. Key players in this sector are concentrating on creating new biomaterials for 3D printing applications to maintain their market presence. For example, in September 2023, Zeus, a South Carolina-based company known for its advanced polymer solutions across various industries, including medical, aerospace, energy, automotive, and fiber optics, introduced next-generation tubing for bioresorbable vascular scaffolds called Absorv(TM) XSE. This product aims to enhance medical device capabilities, especially in vascular treatments. Absorv(TM) XSE represents a major advancement in bioresorbable medical devices, potentially improving patient outcomes and broadening treatment options. This innovative offering allows for extensive customization with a variety of polymer choices and expanded sizes, which facilitate tailored mechanical and absorption properties. It also ensures improved wall thickness uniformity for consistent production and provides approximately 25% more usable scaffolds post-laser cutting compared to previous models.

Leading companies in the bioresorbable medical material market are focusing on new product launches to gain a competitive advantage. For instance, in October 2023, Ashland Global, a US-based chemicals company, unveiled its bioresorbable polymers technology platform. This adaptable platform can be extended across various market segments and applications, including long-acting injectables for chronic disease management and animal health, advanced drug delivery systems to enhance mRNA delivery, as well as applications in medical devices and regenerative medicine, such as dermal fillers, sutures, screws, and other products.

In April 2024, ProMed Pharma, a US-based contract manufacturer specializing in polymer-based drug-releasing dosage forms and combination device components, acquired SpineThera for an undisclosed sum. This acquisition is strategically aimed at bolstering ProMed Pharma's market position by enhancing its manufacturing capabilities, broadening its product range, and supporting innovative drug development efforts. SpineThera is a US-based clinical-stage pharmaceutical company focused on creating innovative injectable drugs, particularly through its proprietary micro-suspension platform technology.

Major companies operating in the bioresorbable medical material market include Johnson & Johnson, Abbott Laboratories, Medtronic PLC, Kureha Corporation, Evonik Industries AG, Stryker Corporation, Toray Industries Inc., Mitsui Chemicals Inc., Arkema S.A., Royal DSM N.V., Zimmer Biomet Holdings Inc., Ashland Global Holdings Inc., Corbion N.V., Zeus Industrial Products Inc., Unitika Ltd., Danimer Scientific, Synbra Technology, KLS Martin Group, Durect Corporation, Putnam Plastics Corporation, Zhejiang Haizheng Biomaterials Co. Ltd., NatureWorks LLC, Foster Corporation, Poly-Med Inc., Futerro S.A., TotalEnergies Corbion B.V.

North America was the largest region in the bioresorbable medical material market in 2024. Asia-Pacific is expected to be the fastest-growing region in the bioresorbable medical material market report during the forecast period. The regions covered in the bioresorbable medical material market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioresorbable medical material market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioresorbable medical materials market consists of sales of chitosan, collagen, and calcium phosphates. Values in this market are 'factory gat' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioresorbable Medical Material Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioresorbable medical material market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioresorbable medical material ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioresorbable medical material market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Polylactic Acid (PLA); Polyglycolic Acid (PGA); Polysaccharides; Polycaprolactone (PCL); Poly Lactic-Co-Glycolic Acid (PLGA)
• 2) By Application: Drug Delivery; Orthopedics; Other Applications
• 3) By End-User: Hospitals And Clinics; Ambulatory Surgical Centers; Research Institutes; Other End-Users
• Subsegments:
• 1) By Polylactic Acid (PLA): Low Molecular Weight PLA; High Molecular Weight PLA; PLA Blends
• 2) By Polyglycolic Acid (PGA): Homopolymer PGA; Copolymer PGA
• 3) By Polysaccharides: Chitosan; Alginate; Hyaluronic Acid Derivatives
• 4) By Polycaprolactone (PCL): Standard PCL; PCL Copolymers
• 5) By Poly Lactic-Co-Glycolic Acid (PLGA): 50:50 PLGA; 75:25 PLGA; Other PLGA Ratios
• Companies Mentioned: Johnson & Johnson; Abbott Laboratories; Medtronic PLC; Kureha Corporation; Evonik Industries AG; Stryker Corporation; Toray Industries Inc.; Mitsui Chemicals Inc.; Arkema S.A.; Royal DSM N.V.; Zimmer Biomet Holdings Inc.; Ashland Global Holdings Inc.; Corbion N.V.; Zeus Industrial Products Inc.; Unitika Ltd.; Danimer Scientific; Synbra Technology; KLS Martin Group; Durect Corporation; Putnam Plastics Corporation; Zhejiang Haizheng Biomaterials Co. Ltd.; NatureWorks LLC; Foster Corporation; Poly-Med Inc.; Futerro S.A.; TotalEnergies Corbion B.V.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioresorbable Medical Material Market Characteristics

3. Bioresorbable Medical Material Market Trends And Strategies

4. Bioresorbable Medical Material Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Bioresorbable Medical Material Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bioresorbable Medical Material PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bioresorbable Medical Material Market Growth Rate Analysis
• 5.4. Global Bioresorbable Medical Material Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bioresorbable Medical Material Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bioresorbable Medical Material Total Addressable Market (TAM)

6. Bioresorbable Medical Material Market Segmentation

• 6.1. Global Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polylactic Acid (PLA)
• Polyglycolic Acid (PGA)
• Polysaccharides
• Polycaprolactone (PCL)
• Poly Lactic-Co-Glycolic Acid (PLGA)
• 6.2. Global Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Delivery
• Orthopedics
• Other Applications
• 6.3. Global Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Ambulatory Surgical Centers
• Research Institutes
• Other End-Users
• 6.4. Global Bioresorbable Medical Material Market, Sub-Segmentation Of Polylactic Acid (PLA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low Molecular Weight PLA
• High Molecular Weight PLA
• PLA Blends
• 6.5. Global Bioresorbable Medical Material Market, Sub-Segmentation Of Polyglycolic Acid (PGA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Homopolymer PGA
• Copolymer PGA
• 6.6. Global Bioresorbable Medical Material Market, Sub-Segmentation Of Polysaccharides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chitosan
• Alginate
• Hyaluronic Acid Derivatives
• 6.7. Global Bioresorbable Medical Material Market, Sub-Segmentation Of Polycaprolactone (PCL), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard PCL
• PCL Copolymers
• 6.8. Global Bioresorbable Medical Material Market, Sub-Segmentation Of Poly Lactic-Co-Glycolic Acid (PLGA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 50:50 PLGA
• 75:25 PLGA
• Other PLGA Ratios

7. Bioresorbable Medical Material Market Regional And Country Analysis

• 7.1. Global Bioresorbable Medical Material Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bioresorbable Medical Material Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bioresorbable Medical Material Market

• 8.1. Asia-Pacific Bioresorbable Medical Material Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bioresorbable Medical Material Market

• 9.1. China Bioresorbable Medical Material Market Overview
• 9.2. China Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bioresorbable Medical Material Market

• 10.1. India Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bioresorbable Medical Material Market

• 11.1. Japan Bioresorbable Medical Material Market Overview
• 11.2. Japan Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bioresorbable Medical Material Market

• 12.1. Australia Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bioresorbable Medical Material Market

• 13.1. Indonesia Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bioresorbable Medical Material Market

• 14.1. South Korea Bioresorbable Medical Material Market Overview
• 14.2. South Korea Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bioresorbable Medical Material Market

• 15.1. Western Europe Bioresorbable Medical Material Market Overview
• 15.2. Western Europe Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bioresorbable Medical Material Market

• 16.1. UK Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bioresorbable Medical Material Market

• 17.1. Germany Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bioresorbable Medical Material Market

• 18.1. France Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bioresorbable Medical Material Market

• 19.1. Italy Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bioresorbable Medical Material Market

• 20.1. Spain Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bioresorbable Medical Material Market

• 21.1. Eastern Europe Bioresorbable Medical Material Market Overview
• 21.2. Eastern Europe Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bioresorbable Medical Material Market

• 22.1. Russia Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bioresorbable Medical Material Market

• 23.1. North America Bioresorbable Medical Material Market Overview
• 23.2. North America Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bioresorbable Medical Material Market

• 24.1. USA Bioresorbable Medical Material Market Overview
• 24.2. USA Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bioresorbable Medical Material Market

• 25.1. Canada Bioresorbable Medical Material Market Overview
• 25.2. Canada Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bioresorbable Medical Material Market

• 26.1. South America Bioresorbable Medical Material Market Overview
• 26.2. South America Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bioresorbable Medical Material Market

• 27.1. Brazil Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bioresorbable Medical Material Market

• 28.1. Middle East Bioresorbable Medical Material Market Overview
• 28.2. Middle East Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bioresorbable Medical Material Market

• 29.1. Africa Bioresorbable Medical Material Market Overview
• 29.2. Africa Bioresorbable Medical Material Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bioresorbable Medical Material Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bioresorbable Medical Material Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bioresorbable Medical Material Market Competitive Landscape And Company Profiles

• 30.1. Bioresorbable Medical Material Market Competitive Landscape
• 30.2. Bioresorbable Medical Material Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Kureha Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis

31. Bioresorbable Medical Material Market Other Major And Innovative Companies

• 31.1. Stryker Corporation
• 31.2. Toray Industries Inc.
• 31.3. Mitsui Chemicals Inc.
• 31.4. Arkema S.A.
• 31.5. Royal DSM N.V.
• 31.6. Zimmer Biomet Holdings Inc.
• 31.7. Ashland Global Holdings Inc.
• 31.8. Corbion N.V.
• 31.9. Zeus Industrial Products Inc.
• 31.10. Unitika Ltd.
• 31.11. Danimer Scientific
• 31.12. Synbra Technology
• 31.13. KLS Martin Group
• 31.14. Durect Corporation
• 31.15. Putnam Plastics Corporation

32. Global Bioresorbable Medical Material Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioresorbable Medical Material Market

34. Recent Developments In The Bioresorbable Medical Material Market

35. Bioresorbable Medical Material Market High Potential Countries, Segments and Strategies

• 35.1 Bioresorbable Medical Material Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bioresorbable Medical Material Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bioresorbable Medical Material Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer